Erythropoiesis stimulating agents have limited therapeutic activity in transfusion-dependent patients with primary myelofibrosis regardless of serum erythropoietin level

被引:63
作者
Huang, Jocelin [1 ]
Tefferi, Ayalew [1 ]
机构
[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN 55905 USA
关键词
RECOMBINANT-HUMAN-ERYTHROPOIETIN; MYELOID METAPLASIA; IDIOPATHIC MYELOFIBROSIS; ANEMIA;
D O I
10.1111/j.1600-0609.2009.01266.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:154 / 155
页数:2
相关论文
共 10 条
  • [1] SERUM ERYTHROPOIETIN IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA
    BAROSI, G
    LIBERATO, LN
    GUARNONE, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1993, 83 (03) : 365 - 369
  • [2] CAZZOLA M, 1992, BLOOD, V79, P29
  • [3] Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia:: results in 20 patients and review of the literature
    Cervantes, F
    Alvarez-Larrán, A
    Hernández-Boluda, JC
    Sureda, A
    Torrebadell, M
    Montserrat, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (04) : 399 - 403
  • [4] Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin
    Hasselbalch, HC
    Clausen, NT
    Jensen, BA
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2002, 70 (02) : 92 - 99
  • [5] Risk factors for leukemic transformation in patients with primary myelofibrosis
    Huang, Jocelin
    Li, Chin-Yang
    Mesa, Ruben A.
    Wu, Wentling
    Hanson, Curtis A.
    Pardanani, Animesh
    Tefferi, Ayalew
    [J]. CANCER, 2008, 112 (12) : 2726 - 2732
  • [6] Erythropoietin after a century of research: younger than ever
    Jelkmann, Wolfgang
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (03) : 183 - 205
  • [7] Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2V617F and response to erythropoietin therapy
    Tefferi, A
    Strand, JJ
    Lasho, TL
    Elliott, MA
    Li, CY
    Mesa, RA
    Dewald, GW
    [J]. CANCER, 2006, 106 (08) : 1739 - 1743
  • [8] RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA
    TEFFERI, A
    SILVERSTEIN, MN
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (04) : 893 - 893
  • [9] Pharmaceutical erythropoietin use in patients with cancer: Is it time to abandon ship or just drop anchor?
    Tefferi, Ayalew
    [J]. MAYO CLINIC PROCEEDINGS, 2007, 82 (11) : 1316 - 1318
  • [10] Recombinant human erythropoietin for the treatment of anaemia in patients with chronic idiopathic myelofibrosis
    Tsiara, S. N.
    Chaidos, A.
    Bourantas, L. K.
    Kapsali, H. D.
    Bourantas, K. L.
    [J]. ACTA HAEMATOLOGICA, 2007, 117 (03) : 156 - 161